373 related articles for article (PubMed ID: 16310678)
41. Gestation trophoblastic diseases: management of cases with persistent low human chorionic gonadotropin results.
Cole LA; Kohorn E; Smith HO
Obstet Gynecol Clin North Am; 2005 Dec; 32(4):615-26. PubMed ID: 16310675
[TBL] [Abstract][Full Text] [Related]
42. Twenty-five years' clinical experience with placental site trophoblastic tumors.
Papadopoulos AJ; Foskett M; Seckl MJ; McNeish I; Paradinas FJ; Rees H; Newlands ES
J Reprod Med; 2002 Jun; 47(6):460-4. PubMed ID: 12092014
[TBL] [Abstract][Full Text] [Related]
43. Current issues in the histopathology of gestational trophoblastic tumors.
Sebire NJ; Lindsay I
Fetal Pediatr Pathol; 2010; 29(1):30-44. PubMed ID: 20055562
[TBL] [Abstract][Full Text] [Related]
44. Current approaches to diagnosis and treatment of gestational trophoblastic disease.
Smith DB; O'Reilly SM; Newlands ES
Curr Opin Obstet Gynecol; 1993 Feb; 5(1):84-91. PubMed ID: 8381037
[TBL] [Abstract][Full Text] [Related]
45. Host and risk factors for gestational trophoblastic disease: a hospital-based analysis from India.
Kumar N; Saxena YK; Rathi AK; Chitra R; Kumar P
Med Sci Monit; 2003 Oct; 9(10):CR442-7. PubMed ID: 14523334
[TBL] [Abstract][Full Text] [Related]
46. Single-dose actinomycin D: Efficacy in the prophylaxis of postmolar gestational trophoblastic neoplasia in adolescents with high-risk hydatidiform mole.
Uberti EM; Diestel MC; Guimarães FE; De Nápoli G; Schmid H
Gynecol Oncol; 2006 Aug; 102(2):325-32. PubMed ID: 16476471
[TBL] [Abstract][Full Text] [Related]
47. Phase II trial of pulse dactinomycin as salvage therapy for failed low-risk gestational trophoblastic neoplasia: a Gynecologic Oncology Group study.
Covens A; Filiaci VL; Burger RA; Osborne R; Chen MD;
Cancer; 2006 Sep; 107(6):1280-6. PubMed ID: 16900525
[TBL] [Abstract][Full Text] [Related]
48. Treatment of metastatic gestational choriocarcinoma with oral methotrexate in a combat environment.
Farley JH; Heathcock RB; Branch W; Larsen W; Homas D
Obstet Gynecol; 2005 May; 105(5 Pt 2):1250-4. PubMed ID: 15863599
[TBL] [Abstract][Full Text] [Related]
49. Gestational trophoblastic neoplasia.
Soper JT
Curr Opin Obstet Gynecol; 1990 Feb; 2(1):92-7. PubMed ID: 1966319
[TBL] [Abstract][Full Text] [Related]
50. [Combination chemotherapy with etoposide and cisplatin for high-risk, chemorefractory and recurrent gestational trophoblastic neoplasia].
Jiang J; Nan FF; Yang XS; Zhang YZ; Wang B; Kong BH
Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):595-9. PubMed ID: 17983513
[TBL] [Abstract][Full Text] [Related]
51. [Effects of primary chemotherapy with single methotrexate on low-risk gestational trophoblastic neoplasia and influencing factors thereof].
Chen YX; Shen YM; Qian JH; Xie X
Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(30):2109-12. PubMed ID: 16313819
[TBL] [Abstract][Full Text] [Related]
52. The role of repeat uterine evacuation in the management of persistent gestational trophoblastic disease.
Pezeshki M; Hancock BW; Silcocks P; Everard JE; Coleman J; Gillespie AM; Tidy J; Coleman RE
Gynecol Oncol; 2004 Dec; 95(3):423-9. PubMed ID: 15581942
[TBL] [Abstract][Full Text] [Related]
53. Comparison of 2 commercially available human chorionic gonadotropin immunoassays used in the management of gestational trophoblastic neoplasia.
Matsui H; Kihara M; Usui H; Tate S; Mitsuhashi A; Shozu M
J Reprod Med; 2009 Oct; 54(10):631-5. PubMed ID: 20677483
[TBL] [Abstract][Full Text] [Related]
54. Influence of hydatidiform mole follow-up setting on postmolar gestational trophoblastic neoplasia outcomes: a cohort study.
Dantas PR; Maestá I; Cortés-Charry R; Growdon WB; Braga A; Rudge MV; Berkowitz RS
J Reprod Med; 2012; 57(7-8):305-9. PubMed ID: 22838246
[TBL] [Abstract][Full Text] [Related]
55. What we know about low-level hCG: definition, classification and management.
Kohorn EI
J Reprod Med; 2004 Jun; 49(6):433-7. PubMed ID: 15283049
[TBL] [Abstract][Full Text] [Related]
56. The prognosis of gestational trophoblastic neoplasia patient with residual lung tumor after completing treatment.
Yang J; Xiang Y; Wan X; Yang X
Gynecol Oncol; 2006 Nov; 103(2):479-82. PubMed ID: 16631244
[TBL] [Abstract][Full Text] [Related]
57. Advances in the clinical laboratory detection of gestational trophoblastic disease.
Seki K; Matsui H; Sekiya S
Clin Chim Acta; 2004 Nov; 349(1-2):1-13. PubMed ID: 15469850
[TBL] [Abstract][Full Text] [Related]
58. Comparison of human chorionic gonadotropin +beta and invasive trophoblast antigen disappearance rates in serum after evacuation of molar pregnancy.
Van Trommel NE; Sweep FC; Ross HA; Massuger LF; Thomas CM
Int J Mol Med; 2006 Oct; 18(4):705-11. PubMed ID: 16964426
[TBL] [Abstract][Full Text] [Related]
59. Risk factors for persistent gestational trophoblastic neoplasia.
Kuyumcuoglu U; Guzel AI; Erdemoglu M; Celik Y
J Exp Ther Oncol; 2011; 9(1):81-4. PubMed ID: 21275269
[TBL] [Abstract][Full Text] [Related]
60. [Analysis of death causes of gestational trophoblastic neoplasia patients].
Yang JJ; Xiang Y; Wan XR; Li Q; He FQ; Yang XY
Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):403-7. PubMed ID: 16831365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
